RETRACTED ARTICLE: The molecular mechanism of microRNA-145 to suppress invasion–metastasis cascade in gastric cancer
Invasion and metastasis are the major features of malignant tumors that are responsible for 90% of cancer-related deaths. Recently, microRNAs have been discovered to have a role in suppressing tumor metastasis. This study's aim was to clarify the roles of miR-145 in gastric carcinomas and its u...
Gespeichert in:
Veröffentlicht in: | Oncogene 2013-01, Vol.32 (4), p.491-501 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Invasion and metastasis are the major features of malignant tumors that are responsible for 90% of cancer-related deaths. Recently, microRNAs have been discovered to have a role in suppressing tumor metastasis. This study's aim was to clarify the roles of miR-145 in gastric carcinomas and its underlying molecular mechanism in regulating tumor metastasis. Here, we demonstrate a stepwise downregulation of miR-145 level in nontumorous gastric mucosa, primary gastric cancers and their secondary metastases.
In vitro
analysis of miR-145's ectopic expression and loss-of-function suggests that it suppresses gastric cancer cell migration and invasion.
In vivo
spontaneous metastasis and experimental metastasis assay further confirm its function in suppressing the invasion–metastasis cascade, including impairing local invasion and inhibiting hematogenous metastasis in gastric cancers. Furthermore, we identified a novel mechanism of miR-145 to suppress metastasis.
N-cadherin
(CDH2)
was proved to be a direct target of miR-145, using luciferase assay and western blot. Re-expressing
N-cadherin
in miR-145-transfected cells reverses their migration and invasion defects. Although not a direct target of miR-145, matrix metallopeptidase 9 (MMP9), but not MMP2, was also significantly decreased in miR-145-expressing cells. We suggest that miR-145 suppresses tumor metastasis by inhibiting
N-cadherin
protein translation, and then indirectly downregulates its downstream effector MMP9. |
---|---|
ISSN: | 0950-9232 1476-5594 |
DOI: | 10.1038/onc.2012.61 |